Histopathologic Response Is a Positive Predictor of Overall Survival in Patients Undergoing Neoadjuvant/Perioperative Chemotherapy for Locally Advanced Gastric or Gastroesophageal Junction Cancers—Analysis from a Large Single Center Cohort in Germany

There is conflicting evidence regarding the efficacy of neoadjuvant/perioperative chemotherapy (NCT) for gastro-esophageal cancer (GEC) on overall survival. This study aimed to analyze the outcomes of multimodal treatments in a large single center cohort. We performed a retrospective analysis of pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Schirren, Rebekka, Novotny, Alexander, Friess, Helmut, Reim, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465424/
https://www.ncbi.nlm.nih.gov/pubmed/32796715
http://dx.doi.org/10.3390/cancers12082244

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465424/
https://www.ncbi.nlm.nih.gov/pubmed/32796715
http://dx.doi.org/10.3390/cancers12082244

Ejemplares similares